1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Breast Cancer Liquid Biopsy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Circulating Tumor Cells (CTCs)
        1.2.3 Cell-Free DNA (CfDNA)
        1.2.4 Extracellular Vesicles (EVs)
        1.2.5 Other Circulating Biomarkers
    1.3 Market by Application
        1.3.1 Global Breast Cancer Liquid Biopsy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Diagnostic Centers
        1.3.4 Laboratories
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Breast Cancer Liquid Biopsy Market Perspective (2017-2028)
    2.2 Breast Cancer Liquid Biopsy Growth Trends by Region
        2.2.1 Breast Cancer Liquid Biopsy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Breast Cancer Liquid Biopsy Historic Market Size by Region (2017-2022)
        2.2.3 Breast Cancer Liquid Biopsy Forecasted Market Size by Region (2023-2028)
    2.3 Breast Cancer Liquid Biopsy Market Dynamics
        2.3.1 Breast Cancer Liquid Biopsy Industry Trends
        2.3.2 Breast Cancer Liquid Biopsy Market Drivers
        2.3.3 Breast Cancer Liquid Biopsy Market Challenges
        2.3.4 Breast Cancer Liquid Biopsy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Breast Cancer Liquid Biopsy Players by Revenue
        3.1.1 Global Top Breast Cancer Liquid Biopsy Players by Revenue (2017-2022)
        3.1.2 Global Breast Cancer Liquid Biopsy Revenue Market Share by Players (2017-2022)
    3.2 Global Breast Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Breast Cancer Liquid Biopsy Revenue
    3.4 Global Breast Cancer Liquid Biopsy Market Concentration Ratio
        3.4.1 Global Breast Cancer Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Liquid Biopsy Revenue in 2021
    3.5 Breast Cancer Liquid Biopsy Key Players Head office and Area Served
    3.6 Key Players Breast Cancer Liquid Biopsy Product Solution and Service
    3.7 Date of Enter into Breast Cancer Liquid Biopsy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Breast Cancer Liquid Biopsy Breakdown Data by Type
    4.1 Global Breast Cancer Liquid Biopsy Historic Market Size by Type (2017-2022)
    4.2 Global Breast Cancer Liquid Biopsy Forecasted Market Size by Type (2023-2028)
5 Breast Cancer Liquid Biopsy Breakdown Data by Application
    5.1 Global Breast Cancer Liquid Biopsy Historic Market Size by Application (2017-2022)
    5.2 Global Breast Cancer Liquid Biopsy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Breast Cancer Liquid Biopsy Market Size (2017-2028)
    6.2 North America Breast Cancer Liquid Biopsy Market Size by Type
        6.2.1 North America Breast Cancer Liquid Biopsy Market Size by Type (2017-2022)
        6.2.2 North America Breast Cancer Liquid Biopsy Market Size by Type (2023-2028)
        6.2.3 North America Breast Cancer Liquid Biopsy Market Share by Type (2017-2028)
    6.3 North America Breast Cancer Liquid Biopsy Market Size by Application
        6.3.1 North America Breast Cancer Liquid Biopsy Market Size by Application (2017-2022)
        6.3.2 North America Breast Cancer Liquid Biopsy Market Size by Application (2023-2028)
        6.3.3 North America Breast Cancer Liquid Biopsy Market Share by Application (2017-2028)
    6.4 North America Breast Cancer Liquid Biopsy Market Size by Country
        6.4.1 North America Breast Cancer Liquid Biopsy Market Size by Country (2017-2022)
        6.4.2 North America Breast Cancer Liquid Biopsy Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Breast Cancer Liquid Biopsy Market Size (2017-2028)
    7.2 Europe Breast Cancer Liquid Biopsy Market Size by Type
        7.2.1 Europe Breast Cancer Liquid Biopsy Market Size by Type (2017-2022)
        7.2.2 Europe Breast Cancer Liquid Biopsy Market Size by Type (2023-2028)
        7.2.3 Europe Breast Cancer Liquid Biopsy Market Share by Type (2017-2028)
    7.3 Europe Breast Cancer Liquid Biopsy Market Size by Application
        7.3.1 Europe Breast Cancer Liquid Biopsy Market Size by Application (2017-2022)
        7.3.2 Europe Breast Cancer Liquid Biopsy Market Size by Application (2023-2028)
        7.3.3 Europe Breast Cancer Liquid Biopsy Market Share by Application (2017-2028)
    7.4 Europe Breast Cancer Liquid Biopsy Market Size by Country
        7.4.1 Europe Breast Cancer Liquid Biopsy Market Size by Country (2017-2022)
        7.4.2 Europe Breast Cancer Liquid Biopsy Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Breast Cancer Liquid Biopsy Market Size (2017-2028)
    8.2 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Type
        8.2.1 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Breast Cancer Liquid Biopsy Market Share by Type (2017-2028)
    8.3 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Application
        8.3.1 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Breast Cancer Liquid Biopsy Market Share by Application (2017-2028)
    8.4 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Region
        8.4.1 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Breast Cancer Liquid Biopsy Market Size (2017-2028)
    9.2 Latin America Breast Cancer Liquid Biopsy Market Size by Type
        9.2.1 Latin America Breast Cancer Liquid Biopsy Market Size by Type (2017-2022)
        9.2.2 Latin America Breast Cancer Liquid Biopsy Market Size by Type (2023-2028)
        9.2.3 Latin America Breast Cancer Liquid Biopsy Market Share by Type (2017-2028)
    9.3 Latin America Breast Cancer Liquid Biopsy Market Size by Application
        9.3.1 Latin America Breast Cancer Liquid Biopsy Market Size by Application (2017-2022)
        9.3.2 Latin America Breast Cancer Liquid Biopsy Market Size by Application (2023-2028)
        9.3.3 Latin America Breast Cancer Liquid Biopsy Market Share by Application (2017-2028)
    9.4 Latin America Breast Cancer Liquid Biopsy Market Size by Country
        9.4.1 Latin America Breast Cancer Liquid Biopsy Market Size by Country (2017-2022)
        9.4.2 Latin America Breast Cancer Liquid Biopsy Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Breast Cancer Liquid Biopsy Market Size (2017-2028)
    10.2 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Type
        10.2.1 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Breast Cancer Liquid Biopsy Market Share by Type (2017-2028)
    10.3 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Application
        10.3.1 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Breast Cancer Liquid Biopsy Market Share by Application (2017-2028)
    10.4 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Country
        10.4.1 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 QIAGEN
        11.1.1 QIAGEN Company Details
        11.1.2 QIAGEN Business Overview
        11.1.3 QIAGEN Breast Cancer Liquid Biopsy Introduction
        11.1.4 QIAGEN Revenue in Breast Cancer Liquid Biopsy Business (2017-2022)
        11.1.5 QIAGEN Recent Developments
    11.2 Roche Diagnostics
        11.2.1 Roche Diagnostics Company Details
        11.2.2 Roche Diagnostics Business Overview
        11.2.3 Roche Diagnostics Breast Cancer Liquid Biopsy Introduction
        11.2.4 Roche Diagnostics Revenue in Breast Cancer Liquid Biopsy Business (2017-2022)
        11.2.5 Roche Diagnostics Recent Developments
    11.3 Bio-Rad Laboratories
        11.3.1 Bio-Rad Laboratories Company Details
        11.3.2 Bio-Rad Laboratories Business Overview
        11.3.3 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Introduction
        11.3.4 Bio-Rad Laboratories Revenue in Breast Cancer Liquid Biopsy Business (2017-2022)
        11.3.5 Bio-Rad Laboratories Recent Developments
    11.4 Myriad Genetics
        11.4.1 Myriad Genetics Company Details
        11.4.2 Myriad Genetics Business Overview
        11.4.3 Myriad Genetics Breast Cancer Liquid Biopsy Introduction
        11.4.4 Myriad Genetics Revenue in Breast Cancer Liquid Biopsy Business (2017-2022)
        11.4.5 Myriad Genetics Recent Developments
    11.5 Menarini Silicon Biosystems
        11.5.1 Menarini Silicon Biosystems Company Details
        11.5.2 Menarini Silicon Biosystems Business Overview
        11.5.3 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Introduction
        11.5.4 Menarini Silicon Biosystems Revenue in Breast Cancer Liquid Biopsy Business (2017-2022)
        11.5.5 Menarini Silicon Biosystems Recent Developments
    11.6 Genomic Health
        11.6.1 Genomic Health Company Details
        11.6.2 Genomic Health Business Overview
        11.6.3 Genomic Health Breast Cancer Liquid Biopsy Introduction
        11.6.4 Genomic Health Revenue in Breast Cancer Liquid Biopsy Business (2017-2022)
        11.6.5 Genomic Health Recent Developments
    11.7 Thermo Fisher Scientific
        11.7.1 Thermo Fisher Scientific Company Details
        11.7.2 Thermo Fisher Scientific Business Overview
        11.7.3 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Introduction
        11.7.4 Thermo Fisher Scientific Revenue in Breast Cancer Liquid Biopsy Business (2017-2022)
        11.7.5 Thermo Fisher Scientific Recent Developments
    11.8 Illumina
        11.8.1 Illumina Company Details
        11.8.2 Illumina Business Overview
        11.8.3 Illumina Breast Cancer Liquid Biopsy Introduction
        11.8.4 Illumina Revenue in Breast Cancer Liquid Biopsy Business (2017-2022)
        11.8.5 Illumina Recent Developments
    11.9 Biocept
        11.9.1 Biocept Company Details
        11.9.2 Biocept Business Overview
        11.9.3 Biocept Breast Cancer Liquid Biopsy Introduction
        11.9.4 Biocept Revenue in Breast Cancer Liquid Biopsy Business (2017-2022)
        11.9.5 Biocept Recent Developments
    11.10 Trovagene
        11.10.1 Trovagene Company Details
        11.10.2 Trovagene Business Overview
        11.10.3 Trovagene Breast Cancer Liquid Biopsy Introduction
        11.10.4 Trovagene Revenue in Breast Cancer Liquid Biopsy Business (2017-2022)
        11.10.5 Trovagene Recent Developments
    11.11 Guardant Health
        11.11.1 Guardant Health Company Details
        11.11.2 Guardant Health Business Overview
        11.11.3 Guardant Health Breast Cancer Liquid Biopsy Introduction
        11.11.4 Guardant Health Revenue in Breast Cancer Liquid Biopsy Business (2017-2022)
        11.11.5 Guardant Health Recent Developments
    11.12 RainDance Technologies
        11.12.1 RainDance Technologies Company Details
        11.12.2 RainDance Technologies Business Overview
        11.12.3 RainDance Technologies Breast Cancer Liquid Biopsy Introduction
        11.12.4 RainDance Technologies Revenue in Breast Cancer Liquid Biopsy Business (2017-2022)
        11.12.5 RainDance Technologies Recent Developments
    11.13 MDx Health
        11.13.1 MDx Health Company Details
        11.13.2 MDx Health Business Overview
        11.13.3 MDx Health Breast Cancer Liquid Biopsy Introduction
        11.13.4 MDx Health Revenue in Breast Cancer Liquid Biopsy Business (2017-2022)
        11.13.5 MDx Health Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Breast Cancer Liquid Biopsy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Circulating Tumor Cells (CTCs)
    Table 3. Key Players of Cell-Free DNA (CfDNA)
    Table 4. Key Players of Extracellular Vesicles (EVs)
    Table 5. Key Players of Other Circulating Biomarkers
    Table 6. Global Breast Cancer Liquid Biopsy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Breast Cancer Liquid Biopsy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Breast Cancer Liquid Biopsy Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Breast Cancer Liquid Biopsy Market Share by Region (2017-2022)
    Table 10. Global Breast Cancer Liquid Biopsy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Breast Cancer Liquid Biopsy Market Share by Region (2023-2028)
    Table 12. Breast Cancer Liquid Biopsy Market Trends
    Table 13. Breast Cancer Liquid Biopsy Market Drivers
    Table 14. Breast Cancer Liquid Biopsy Market Challenges
    Table 15. Breast Cancer Liquid Biopsy Market Restraints
    Table 16. Global Breast Cancer Liquid Biopsy Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Breast Cancer Liquid Biopsy Revenue Share by Players (2017-2022)
    Table 18. Global Top Breast Cancer Liquid Biopsy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Liquid Biopsy as of 2021)
    Table 19. Ranking of Global Top Breast Cancer Liquid Biopsy Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Breast Cancer Liquid Biopsy Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Breast Cancer Liquid Biopsy Product Solution and Service
    Table 23. Date of Enter into Breast Cancer Liquid Biopsy Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Breast Cancer Liquid Biopsy Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Breast Cancer Liquid Biopsy Revenue Market Share by Type (2017-2022)
    Table 27. Global Breast Cancer Liquid Biopsy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Breast Cancer Liquid Biopsy Revenue Market Share by Type (2023-2028)
    Table 29. Global Breast Cancer Liquid Biopsy Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Breast Cancer Liquid Biopsy Revenue Share by Application (2017-2022)
    Table 31. Global Breast Cancer Liquid Biopsy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Breast Cancer Liquid Biopsy Revenue Share by Application (2023-2028)
    Table 33. North America Breast Cancer Liquid Biopsy Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Breast Cancer Liquid Biopsy Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Breast Cancer Liquid Biopsy Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Breast Cancer Liquid Biopsy Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Breast Cancer Liquid Biopsy Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Breast Cancer Liquid Biopsy Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Breast Cancer Liquid Biopsy Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Breast Cancer Liquid Biopsy Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Breast Cancer Liquid Biopsy Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Breast Cancer Liquid Biopsy Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Breast Cancer Liquid Biopsy Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Breast Cancer Liquid Biopsy Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Breast Cancer Liquid Biopsy Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Breast Cancer Liquid Biopsy Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Breast Cancer Liquid Biopsy Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Breast Cancer Liquid Biopsy Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Breast Cancer Liquid Biopsy Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Breast Cancer Liquid Biopsy Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Breast Cancer Liquid Biopsy Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Breast Cancer Liquid Biopsy Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Breast Cancer Liquid Biopsy Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Breast Cancer Liquid Biopsy Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Breast Cancer Liquid Biopsy Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Breast Cancer Liquid Biopsy Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Breast Cancer Liquid Biopsy Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Breast Cancer Liquid Biopsy Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Breast Cancer Liquid Biopsy Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Breast Cancer Liquid Biopsy Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Breast Cancer Liquid Biopsy Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Breast Cancer Liquid Biopsy Market Size by Country (2023-2028) & (US$ Million)
    Table 63. QIAGEN Company Details
    Table 64. QIAGEN Business Overview
    Table 65. QIAGEN Breast Cancer Liquid Biopsy Product
    Table 66. QIAGEN Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 67. QIAGEN Recent Developments
    Table 68. Roche Diagnostics Company Details
    Table 69. Roche Diagnostics Business Overview
    Table 70. Roche Diagnostics Breast Cancer Liquid Biopsy Product
    Table 71. Roche Diagnostics Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 72. Roche Diagnostics Recent Developments
    Table 73. Bio-Rad Laboratories Company Details
    Table 74. Bio-Rad Laboratories Business Overview
    Table 75. Bio-Rad Laboratories Breast Cancer Liquid Biopsy Product
    Table 76. Bio-Rad Laboratories Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 77. Bio-Rad Laboratories Recent Developments
    Table 78. Myriad Genetics Company Details
    Table 79. Myriad Genetics Business Overview
    Table 80. Myriad Genetics Breast Cancer Liquid Biopsy Product
    Table 81. Myriad Genetics Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 82. Myriad Genetics Recent Developments
    Table 83. Menarini Silicon Biosystems Company Details
    Table 84. Menarini Silicon Biosystems Business Overview
    Table 85. Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Product
    Table 86. Menarini Silicon Biosystems Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 87. Menarini Silicon Biosystems Recent Developments
    Table 88. Genomic Health Company Details
    Table 89. Genomic Health Business Overview
    Table 90. Genomic Health Breast Cancer Liquid Biopsy Product
    Table 91. Genomic Health Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 92. Genomic Health Recent Developments
    Table 93. Thermo Fisher Scientific Company Details
    Table 94. Thermo Fisher Scientific Business Overview
    Table 95. Thermo Fisher Scientific Breast Cancer Liquid Biopsy Product
    Table 96. Thermo Fisher Scientific Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 97. Thermo Fisher Scientific Recent Developments
    Table 98. Illumina Company Details
    Table 99. Illumina Business Overview
    Table 100. Illumina Breast Cancer Liquid Biopsy Product
    Table 101. Illumina Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 102. Illumina Recent Developments
    Table 103. Biocept Company Details
    Table 104. Biocept Business Overview
    Table 105. Biocept Breast Cancer Liquid Biopsy Product
    Table 106. Biocept Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 107. Biocept Recent Developments
    Table 108. Trovagene Company Details
    Table 109. Trovagene Business Overview
    Table 110. Trovagene Breast Cancer Liquid Biopsy Product
    Table 111. Trovagene Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 112. Trovagene Recent Developments
    Table 113. Guardant Health Company Details
    Table 114. Guardant Health Business Overview
    Table 115. Guardant Health Breast Cancer Liquid Biopsy Product
    Table 116. Guardant Health Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 117. Guardant Health Recent Developments
    Table 118. RainDance Technologies Company Details
    Table 119. RainDance Technologies Business Overview
    Table 120. RainDance Technologies Breast Cancer Liquid Biopsy Product
    Table 121. RainDance Technologies Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 122. RainDance Technologies Recent Developments
    Table 123. MDx Health Company Details
    Table 124. MDx Health Business Overview
    Table 125. MDx Health Breast Cancer Liquid Biopsy Product
    Table 126. MDx Health Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 127. MDx Health Recent Developments
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Breast Cancer Liquid Biopsy Market Share by Type: 2021 VS 2028
    Figure 2. Circulating Tumor Cells (CTCs) Features
    Figure 3. Cell-Free DNA (CfDNA) Features
    Figure 4. Extracellular Vesicles (EVs) Features
    Figure 5. Other Circulating Biomarkers Features
    Figure 6. Global Breast Cancer Liquid Biopsy Market Share by Application: 2021 VS 2028
    Figure 7. Hospitals Case Studies
    Figure 8. Diagnostic Centers Case Studies
    Figure 9. Laboratories Case Studies
    Figure 10. Breast Cancer Liquid Biopsy Report Years Considered
    Figure 11. Global Breast Cancer Liquid Biopsy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Breast Cancer Liquid Biopsy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Breast Cancer Liquid Biopsy Market Share by Region: 2021 VS 2028
    Figure 14. Global Breast Cancer Liquid Biopsy Market Share by Players in 2021
    Figure 15. Global Top Breast Cancer Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Liquid Biopsy as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Breast Cancer Liquid Biopsy Revenue in 2021
    Figure 17. North America Breast Cancer Liquid Biopsy Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Breast Cancer Liquid Biopsy Market Size Market Share by Type (2017-2028)
    Figure 19. North America Breast Cancer Liquid Biopsy Market Size Market Share by Application (2017-2028)
    Figure 20. North America Breast Cancer Liquid Biopsy Market Size Share by Country (2017-2028)
    Figure 21. United States Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Breast Cancer Liquid Biopsy Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Breast Cancer Liquid Biopsy Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Breast Cancer Liquid Biopsy Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Breast Cancer Liquid Biopsy Market Size Share by Country (2017-2028)
    Figure 27. Germany Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Breast Cancer Liquid Biopsy Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Breast Cancer Liquid Biopsy Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Breast Cancer Liquid Biopsy Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Breast Cancer Liquid Biopsy Market Size Share by Region (2017-2028)
    Figure 37. China Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Breast Cancer Liquid Biopsy Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Breast Cancer Liquid Biopsy Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Breast Cancer Liquid Biopsy Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Breast Cancer Liquid Biopsy Market Size Share by Country (2017-2028)
    Figure 47. Mexico Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Breast Cancer Liquid Biopsy Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Breast Cancer Liquid Biopsy Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Breast Cancer Liquid Biopsy Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Breast Cancer Liquid Biopsy Market Size Share by Country (2017-2028)
    Figure 53. Turkey Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. QIAGEN Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
    Figure 57. Roche Diagnostics Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
    Figure 58. Bio-Rad Laboratories Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
    Figure 59. Myriad Genetics Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
    Figure 60. Menarini Silicon Biosystems Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
    Figure 61. Genomic Health Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
    Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
    Figure 63. Illumina Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
    Figure 64. Biocept Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
    Figure 65. Trovagene Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
    Figure 66. Guardant Health Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
    Figure 67. RainDance Technologies Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
    Figure 68. MDx Health Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed